SR biotek Inc.

A270210

KR7270210008

Personal Products

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-19 EDT			5-day change	1st Jan Change
3,900 ^KRW	0.00%		-13.33%	+8.79%

2022	SR biotek Inc. announced that it has received KRW 443.8467 million in funding	CI
2022	SR biotek Inc. announced that it expects to receive KRW 443.8467 million in funding	CI

SR biotek Inc. announced that it has received KRW 9.550138 million in funding

January 05, 2020

On January 6, 2020, SR biotek Inc. (XKON:A270210) closed the transaction. The company issued 104,032 common shares for gross proceeds of KRW 9,550,137.6 in the transaction.

Latest news about SR biotek Inc.

SR biotek Inc. announced that it has received KRW 443.8467 million in funding	22-12-05	CI
SR biotek Inc. announced that it expects to receive KRW 443.8467 million in funding	22-11-20	CI
SR biotek Inc. announced that it expects to receive KRW 999.999 million in funding	22-01-06	CI
SR biotek Inc. announced that it has received KRW 1 billion in funding from Vivozon Inc.	20-04-20	CI
SR biotek Inc. announced that it expects to receive KRW 1 billion in funding	20-04-12	CI
SR biotek Inc. announced that it has received KRW 9.550138 million in funding	20-01-05	CI
Byeongho Song acquired an additional 3.22% stake in SR biotek Inc. from Core Asset Management Co., Ltd. for KRW 300 million.	19-11-28	CI
SR biotek Inc. announced that it expects to receive KRW 10.401766 million in funding	19-11-21	CI
NH Investment & Securities Co., Ltd. acquired 9.7% stake in SR biotek Inc. from Meritz Securities Co., Ltd. for approximately KRW 830 million.	19-02-25	CI
Core Asset Management Co.,Ltd. acquired an additional 9.72% stake in SR biotek Inc. for approximately KRW 830 million.	19-02-20	CI
SR biotek Inc. announced that it has received KRW 700 million in funding	18-11-06	CI
SR biotek Inc. announced that it expects to receive KRW 700 million in funding	18-10-29	CI
Core Asset Management Co., Ltd acquired 17.07% stake in SR biotek Inc. from CSquared Global Asset Management for KRW 1.3 billion.	18-09-06	CI
Meritz Securities Co., Ltd. acquired 9.72% stake in SR biotek Inc. from CSquared Global Asset Management for approximately KRW 770 million.	17-11-29	CI

SR biotek Inc. is a Korea-based company principally engaged in the manufacture and distribution of cosmetics. The Company distributes its products under brand name RAPHITOX and IDENEL LINE. The Company distributes its products within domestic market and to overseas markets.

Sector

Personal Products

More about the company

Sector Cosmetics & Perfumes

	1st Jan change	Capi.
SR BIOTEK INC.	+8.79%	3.67M
KAO CORPORATION	+20.79%	20.77B
GALDERMA GROUP AG	0.00%	19.36B
SHISEIDO COMPANY, LIMITED	+12.56%	12.64B
COTY INC.	-15.78%	9.2B
AMOREPACIFIC CORPORATION	+23.93%	7.88B
PROYA COSMETICS CO.,LTD.	+9.36%	5.98B
NATURA &CO HOLDING S.A.	-2.84%	4.46B
INTER PARFUMS, INC.	-17.38%	3.99B
KOSÉ CORPORATION	-9.81%	3.65B

Cosmetics & Perfumes

SR biotek Inc.

Equities

A270210

KR7270210008

Personal Products

SR biotek Inc. announced that it has received KRW 9.550138 million in funding

Latest news about SR biotek Inc.

Chart SR biotek Inc.

Company Profile

Sector Cosmetics & Perfumes